Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting.

52W Range

6thpctl

Volume

0.51×avg

Market Cap

109.22MUSD

P/E Ratio

-1.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Humacyte, Inc.

HUMANASDAQ Global Select·USD·Closed

Humacyte, Inc.

HUMANASDAQ·USD·Closed

$0.65

−6.15%

$0.65

−$0.04 (6.15%)

52W Range

6thpctl

Volume

0.51×avg

Mkt Cap

109.22MUSD

P/E

-1.3TTM

Div Yield

–ann

HUMA: Humacyte, Inc. Stock Analysis | finqOS